Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.4396
Delayed Data
As of May 27
 -0.0127 / -2.81%
Today’s Change
0.39
Today|||52-Week Range
6.49
-85.10%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close0.45
Today’s open0.45
Day’s range0.42 - 0.46
Volume4,027,223
Average volume (3 months)2,987,505
Market cap$26.9M
Dividend yield--
Data as of 05/27/2016

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+44.24%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
SBOTStellar Biotechnolog...+0.07+2.24%
EBIOEleven Biotherapeuti...-0.04-2.94%
EVARLombard Medical Inc-0.01-0.72%
PARNParnell Pharmaceutic...-0.01-0.64%
Data as of 05/27/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Operating Officer
Terence S. Novak
Chief Financial Officer &
Head-Investor Relations
Sanjay S. Patel
Corporate headquarters
Morristown, New Jersey

Forecasts

Partner Offers

Search for Jobs